CooperCompanies reports fiscal third-quarter 2026 results ended July 31
CooperCompanies reported fiscal third-quarter 2026 results for the period ended July 31, 2026, without disclosing financial figures in the announcement excerpt. The setup remains evidence-light until the full quarter’s revenue, margins and outlook can establish whether the company’s growth profile is improving or slowing.
STOCK PHOTO · FABIO RICCOBONOThe story
CooperCompanies announced results for its fiscal third quarter ended July 31, 2026. The company is a global medical-device maker.
The latest company-level figures are annual results for the fiscal year ended October 31, 2025: revenue was $4.1B, up 5.1% year over year, with a 65.5% gross margin, a 9.2% net margin and $1.87 in diluted EPS. Those figures provide a baseline for comparison.
For CooperCompanies, the key transmission mechanism is operating performance in its medical-device businesses: quarterly sales growth would flow into gross profit and earnings, while margin or guidance changes would affect the valuation assigned to the existing growth profile.
The balance between a positive earnings surprise and a disappointing print depends on the detailed quarterly release or filing, including revenue, EPS, segment performance, margins and forward guidance.
Our read · Wed, Sep 9
The results announcement puts COO’s risk in a holding pattern: its $4.1B annual revenue base and 5.1% growth are supportive, but the quarter’s undisclosed figures leave the earnings read unresolved.
Why. The trade read cannot move beyond neutral because the announcement excerpt confirms the reporting period but supplies no quarterly revenue, earnings, margin or guidance figures. COO’s older fiscal-2025 baseline—$4.1B of revenue, 5.1% year-over-year growth, a 65.5% gross margin and a 9.2% net margin—supports a credible operating franchise, but it does not show whether the July quarter improved or weakened.
Both cases
What could change this view: A full release showing a material earnings miss, margin compression or weaker guidance would invalidate the supportive baseline; stronger-than-expected figures would invalidate the neutral stance.
Who reported it · 1
Keep reading
More on COO
JANA urges Cooper to seek CEO, replace chair and review asset salesLatest on the Wire
Australia’s jobless rate hits 5-year high, markets ramp up rate-cut bets for 2027Trump meets Putin and Xi separately ahead of historic three-way talksHyperscale Data warns of $74.8 million gap for Michigan AI projectAlibaba aided China military-linked lab with AI computing technologyMeta pauses plan to give Zuckerberg new shares without losing controlContinue on the Wire →Latest on the Wire
Meta pauses plan to give Zuckerberg new shares without losing controlFed releases October meeting minutes three weeks after policy decisionXi gives Trump a rare hug at Shenzhen airport as US-China tone softensLagarde says she will leave ECB early to counter election misinformationContinue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookNvidia interim CEO Colette Kress faces first earnings test after HuangNvidia CEO Jensen Huang reportedly resigns as US-China tensions riseAnthropic Said to Guide IPO Pricing Above Market RangeAbout this report
Reported by GlobeNewswire as CooperCompanies Announces Third Quarter 2026 Results
, . Who answers for this
The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →